Induction of methionine-sulfoxide reductases protects neurons from amyloid β-protein insults in vitro and in vivo

Biochemistry

Volumn 50, Issue 49, 2011, Pages 10687-10697

  Moskovitz, Jackob ^a   Maiti, Panchanan ^b   Lopes, Dahabada H J ^b   Oien, Derek B ^a   Attar, Aida ^b,c   Liu, Tingyu ^b   Mittal, Shivina ^b   Hayes, Jane ^b   Bitan, Gal ^b,c  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; ANTIBODY PRODUCTION; ANTIOXIDANT SYSTEMS; C-TERMINAL REGIONS; FIBRILLAR POLYMERS; IN-VITRO; LOW TOXICITY; MOUSE MODELS; NEURONAL CELL; NEUROTOXICITY; STRUCTURAL ALTERATIONS;

AMINO ACIDS; ENZYME ACTIVITY; GLYCOPROTEINS; MAMMALS; OLIGOMERS;

TOXICITY;

AMYLOID BETA PROTEIN; METHIONINE SULFOXIDE REDUCTASE; N ACETYL MET SULFOXIDE; SULFOXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIOXIDANT ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HIPPOCAMPUS; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; HIPPOCAMPUS; METHIONINE; METHIONINE SULFOXIDE REDUCTASES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 82955194515     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi201426b     Document Type: Article

References (60)

1. Floyd, R. A. and Hensley, K. (2002) Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases Neurobiol. Aging 23, 795-807 (Pubitemid 35217704)
2. Sultana, R. and Butterfield, D. A. (2010) Role of oxidative stress in the progression of Alzheimer's disease J. Alzheimer's Dis. 19, 341-353
3. Halliwell, B. (2001) Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment Drugs Aging 18, 685-716 (Pubitemid 32948277)
4. Terman, A. and Brunk, U. T. (2006) Oxidative stress, accumulation of biological 'garbage', and aging Antioxid. Redox Signaling 8, 197-204 (Pubitemid 43324546)
5. Nunomura, A., Perry, G., Pappolla, M. A., Wade, R., Hirai, K., Chiba, S., and Smith, M. A. (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease J. Neurosci. 19, 1959-1964 (Pubitemid 29133374)
6. Selkoe, D. J. (2001) Alzheimer's disease: Genes, proteins, and therapy Physiol. Rev. 81, 741-766 (Pubitemid 32267077)
7. Hardy, J. A. and Higgins, G. A. (1992) Alzheimer's disease: The amyloid cascade hypothesis Science 256, 184-185
8. Roychaudhuri, R., Yang, M., Hoshi, M. M., and Teplow, D. B. (2009) Amyloid β-protein assembly and Alzheimer disease J. Biol. Chem. 284, 4749-4753
9. Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C. S., Petersen, R. B., and Smith, M. A. (2001) Oxidative damage is the earliest event in Alzheimer disease J. Neuropathol. Exp. Neurol. 60, 759-767 (Pubitemid 32678256)
10. Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., Shimohama, S., Cash, A. D., Siedlak, S. L., Harris, P. L. R., Jones, P. K., Petersen, R. B., Perry, G., and Smith, M. A. (2001) Mitochondrial abnormalities in Alzheimer's disease J. Neurosci. 21, 3017-3023 (Pubitemid 32323483)
11. Pratico, D. (2008) Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: Lights and shadows Ann. N.Y. Acad. Sci. 1147, 70-78
12. Dumont, M., Lin, M. T., and Beal, M. F. (2010) Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease J. Alzheimer's Dis. 20 (Suppl. 2) S633-S643
13. Younkin, S. G. (1995) Evidence that Aβ42 is the real culprit in Alzheimer's disease Ann. Neurol. 37, 287-288
14. 35 and amyloid β-protein oligomerization J. Am. Chem. Soc. 125, 15359-15365 (Pubitemid 37532178)
15. Näslund, J., Schierhorn, A., Hellman, U., Lannfelt, L., Roses, A. D., Tjernberg, L. O., Silberring, J., Gandy, S. E., Winblad, B., and Greengard, P. 1994, Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer disease and normal aging Proc. Natl. Acad. Sci. U.S.A. 91, 8378-8382 (Pubitemid 24273667)
16. Kuo, Y. M., Kokjohn, T. A., Beach, T. G., Sue, L. I., Brune, D., Lopez, J. C., Kalback, W. M., Abramowski, D., Sturchler-Pierrat, C., Staufenbiel, M., and Roher, A. E. (2001) Comparative analysis of amyloid-β chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains J. Biol. Chem. 276, 12991-12998
17. Dong, J., Atwood, C. S., Anderson, V. E., Siedlak, S. L., Smith, M. A., Perry, G., and Carey, P. R. (2003) Metal binding and oxidation of amyloid-β within isolated senile plaque cores: Raman microscopic evidence Biochemistry 42, 2768-2773 (Pubitemid 36331519)
18. Boutte, A. M., Woltjer, R. L., Zimmerman, L. J., Stamer, S. L., Montine, K. S., Manno, M. V., Cimino, P. J., Liebler, D. C., and Montine, T. J. (2006) Selectively increased oxidative modifications mapped to detergent-insoluble forms of Aβ and β-III tubulin in Alzheimer's disease FASEB J. 20, 1473-1483 (Pubitemid 44943855)
19. Choi, J., Sullards, M. C., Olzmann, J. A., Rees, H. D., Weintraub, S. T., Bostwick, D. E., Gearing, M., Levey, A. I., Chin, L. S., and Li, L. (2006) Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases J. Biol. Chem. 281, 10816-10824 (Pubitemid 43855504)
20. Ali, F. E., Separovic, F., Barrow, C. J., Cherny, R. A., Fraser, F., Bush, A. I., Masters, C. L., and Barnham, K. J. (2005) Methionine regulates copper/hydrogen peroxide oxidation products of Aβ J. Pept. Sci. 11, 353-360 (Pubitemid 40796677)
21. Ejiri, S. I., Weissbach, H., and Brot, N. (1979) Reduction of methionine sulfoxide to methionine by Escherichia coli J. Bacteriol. 139, 161-164 (Pubitemid 9227507)
22. Oien, D. B. and Moskovitz, J. (2008) Substrates of the methionine sulfoxide reductase system and their physiological relevance Curr. Top. Dev. Biol. 80, 93-133
23. Moskovitz, J., Weissbach, H., and Brot, N. (1996) Cloning the expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins Proc. Natl. Acad. Sci. U.S.A. 93, 2095-2099 (Pubitemid 26079886)
24. Kim, G., Cole, N. B., Lim, J. C., Zhao, H., and Levine, R. L. (2010) Dual sites of protein initiation control the localization and myristoylation of methionine sulfoxide reductase A J. Biol. Chem. 285, 18085-18094
25. Stadtman, E. R., Moskovitz, J., Berlett, B. S., and Levine, R. L. (2002) Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism Mol. Cell. Biochem. 234, 3-9 (Pubitemid 34777836)
26. Gabbita, S. P., Aksenov, M. Y., Lovell, M. A., and Markesbery, W. R. (1999) Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain J. Neurochem. 73, 1660-1666 (Pubitemid 29440169)
27. Moskovitz, J., Bar-Noy, S., Williams, W. M., Requena, J., Berlett, B. S., and Stadtman, E. R. (2001) Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals Proc. Natl. Acad. Sci. U.S.A. 98, 12920-12925 (Pubitemid 33051295)
28. Pal, R., Oien, D. B., Ersen, F. Y., and Moskovitz, J. (2007) Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse Exp. Brain Res. 180, 765-774 (Pubitemid 46988121)
29. Oien, D. B., Osterhaus, G. L., Latif, S. A., Pinkston, J. W., Fulks, J., Johnson, M., Fowler, S. C., and Moskovitz, J. (2008) MsrA knockout mouse exhibits abnormal behavior and brain dopamine levels Free Radical Biol. Med. 45, 193-200
30. Moskovitz, J., Rahman, M. A., Strassman, J., Yancey, S. O., Kushner, S. R., Brot, N., and Weissbach, H. (1995) Escherichia coli peptide methionine sulfoxide reductase gene: Regulation of expression and role in protecting against oxidative damage J. Bacteriol. 177, 502-507
31. Chung, H., Kim, A. K., Jung, S. A., Kim, S. W., Yu, K., and Lee, J. H. (2010) The Drosophila homolog of methionine sulfoxide reductase A extends lifespan and increases nuclear localization of FOXO FEBS Lett. 584, 3609-3614
32. Moskovitz, J., Flescher, E., Berlett, B. S., Azare, J., Poston, J. M., and Stadtman, E. R. (1998) Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress Proc. Natl. Acad. Sci. U.S.A. 95, 14071-14075 (Pubitemid 28549322)
33. Butterfield, D. A. and Boyd-Kimball, D. (2005) The critical role of methionine 35 in Alzheimer's amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity Biochim. Biophys. Acta 1703, 149-156 (Pubitemid 40170438)
34. Hou, L., Kang, I., Marchant, R. E., and Zagorski, M. G. (2002) Methionine 35 oxidation reduces fibril assembly of the amyloid β-(1-42) peptide of Alzheimer's disease J. Biol. Chem. 277, 40173-40176 (Pubitemid 35215584)
35. ox Eur. J. Biochem. 268, 5930-5936 (Pubitemid 33079329)
36. Yan, Y., McCallum, S. A., and Wang, C. (2008) M35 oxidation induces Aβ40-like structural and dynamical changes in Aβ42 J. Am. Chem. Soc. 130, 5394-5395 (Pubitemid 351612926)
37. Maiti, P., Piacentini, R., Ripoli, C., Grassi, C., and Bitan, G. (2010) Surprising toxicity and assembly behavior of amyloid β-protein oxidized to sulfone Biochem. J. 443, 323-332
38. Triguero, L., Singh, R., and Prabhakar, R. (2008) Comparative molecular dynamics studies of wild-type and oxidized forms of full-length Alzheimer amyloid β-peptides Aβ(1-40) and Aβ(1-42) J. Phys. Chem. B 112, 7123-7131
39. Misiti, F., Clementi, M. E., and Giardina, B. (2010) Oxidation of methionine 35 reduces toxicity of the amyloid β-peptide(1-42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function Neurochem. Int. 56, 597-602
40. Rahimi, F., Maiti, P., and Bitan, G. (2009) Photo-induced cross-linking of unmodified proteins (PICUP) applied to amyloidogenic peptides J. Visual Exp. 1071 doi: 10.3791/1071
41. Fradinger, E. A., Monien, B. H., Urbanc, B., Lomakin, A., Tan, M., Li, H., Spring, S. M., Condron, M. M., Cruz, L., Xie, C. W., Benedek, G. B., and Bitan, G. (2008) C-terminal peptides coassemble into Aβ42 oligomers and protect neurons against Aβ42-induced neurotoxicity Proc. Natl. Acad. Sci. U.S.A. 105, 14175-14180
42. Maiti, P., Lomakin, A., Benedek, G. B., and Bitan, G. (2010) Despite its role in assembly, methionine 35 is not necessary for amyloid β-protein toxicity J. Neurochem. 113, 1252-1262
43. Jankowsky, J. L., Slunt, H. H., Gonzales, V., Jenkins, N. A., Copeland, N. G., and Borchelt, D. R. (2004) APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1 Neurobiol. Aging 25, 885-892 (Pubitemid 38813168)
44. Andersson, M., Ostman, A., Westermark, B., and Heldin, C. H. (1994) Characterization of the retention motif in the C-terminal part of the long splice form of platelet-derived growth factor A-chain J. Biol. Chem. 269, 926-930 (Pubitemid 24032465)
45. Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., Younkin, S. G., and Borchelt, D. R. (2004) Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: Evidence for augmentation of a 42-specific γ secretase Hum. Mol. Genet. 13, 159-170 (Pubitemid 38111354)
46. Andersson, A., Bohman, S., Borg, L. A., Paulsson, J. F., Schultz, S. W., Westermark, G. T., and Westermark, P. (2008) Amyloid deposition in transplanted human pancreatic islets: A conceivable cause of their long-term failure Exp. Diabetes Res. 2008, 562985
47. Ringman, J. M., Fithian, A. T., Gylys, K., Cummings, J. L., Coppola, G., Elashoff, D., Pratico, D., Moskovitz, J., and Bitan, G. (2011) Plasma methionine sulfoxide in persons with familial Alzheimer's disease mutations, submitted for publication.
48. Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J., and Frosch, M. P. (2006) Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease Neurobiol. Dis. 24, 516-524 (Pubitemid 44716680)
49. Ripoli, C., Piacentini, R., Riccardi, E., Leone, L., Bitan, G., and Grassi, C. (2011) Synaptotoxic effects of different amyloid β-protein analogues in rodent hippocampal neurons and brain slices, submitted for publication.
50. Moskovitz, J. and Stadtman, E. R. (2003) Selenium-deficient diet enhances protein oxidation and affects methionine sulfoxide reductase (MsrB) protein level in certain mouse tissues Proc. Natl. Acad. Sci. U.S.A. 100, 7486-7490 (Pubitemid 36759996)
51. Hansel, A., Kuschel, L., Hehl, S., Lemke, C., Agricola, H. J., Hoshi, T., and Heinemann, S. H. (2002) Mitochondrial targeting of the human peptide methionine sulfoxide reductase (MSRA), an enzyme involved in the repair of oxidized proteins FASEB J. 16, 911-913
52. Marchetti, M. A., Pizarro, G. O., Sagher, D., Deamicis, C., Brot, N., Hejtmancik, J. F., Weissbach, H., and Kantorow, M. (2005) Methionine sulfoxide reductases B1, B2, and B3 are present in the human lens and confer oxidative stress resistance to lens cells Invest. Ophthalmol. Visual Sci. 46, 2107-2112
53. Oien, D. B., Shinogle, H. E., Moore, D. S., and Moskovitz, J. (2009) Clearance and phosphorylation of α-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells J. Mol. Neurosci. 39, 323-332
54. Schenk, D. B., Seubert, P., Grundman, M., and Black, R. (2005) Aβ immunotherapy: Lessons learned for potential treatment of Alzheimer's disease Neurodegener. Dis. 2, 255-260 (Pubitemid 43805909)
55. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D., and Seubert, P. (1999) Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400, 173-177 (Pubitemid 29327547)
56. Nicoll, J. A., Wilkinson, D., Holmes, C., Steart, P., Markham, H., and Weller, R. O. (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: A case report Nat. Med. 9, 448-452 (Pubitemid 36460079)
57. Goni, F., Prelli, F., Ji, Y., Scholtzova, H., Yang, J., Sun, Y., Liang, F. X., Kascsak, R., Mehta, P., and Wisniewski, T. (2010) Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease PLoS One 5, e13391
58. Oien, D. B., Canello, T., Gabizon, R., Gasset, M., Lundquist, B. L., Burns, J. M., and Moskovitz, J. (2009) Detection of oxidized methionine in selected proteins, cellular extracts and blood serums by novel anti-methionine sulfoxide antibodies Arch. Biochem. Biophys. 485, 35-40
59. Bayer, T. A., Schafer, S., Breyhan, H., Wirths, O., Treiber, C., and Multhaup, G. (2006) A vicious circle: Role of oxidative stress, intraneuronal Aβ and Cu in Alzheimer's disease Clin. Neuropathol. 25, 163-171 (Pubitemid 44047901)
60. Moskovitz, J., Berlett, B. S., Poston, J. M., and Stadtman, E. R. (1997) The yeast peptide-methionine sulfoxide reductase functions as an antioxidant in vivo Proc. Natl. Acad. Sci. U.S.A. 94, 9585-9589 (Pubitemid 27408105)